BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puangpetch A, Tiyasirichokchai R, Pakakasama S, Wiwattanakul S, Anurathapan U, Hongeng S, Sukasem C. NUDT15 genetic variants are related to thiopurine-induced neutropenia in Thai children with acute lymphoblastic leukemia. Pharmacogenomics 2020;21:403-10. [PMID: 32308129 DOI: 10.2217/pgs-2019-0177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pai AA, Mohan A, Benjamin ESB, Illangeswaran RSS, Xavier Raj I, Janet NB, Arunachalam AK, Kavitha ML, Kulkarni U, Devasia AJ, Fouzia NA, Abraham A, Srivastava A, George B, Mathews V, Korula A, Balasubramanian P. NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy. Pharmgenomics Pers Med 2021;14:1303-13. [PMID: 34629890 DOI: 10.2147/PGPM.S325813] [Reference Citation Analysis]
2 Tanaka Y, Saito Y. Importance of NUDT15 Polymorphisms in Thiopurine Treatments. J Pers Med 2021;11:778. [PMID: 34442422 DOI: 10.3390/jpm11080778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pu G, Wang Y, Duan S, Chen J, Yang C, Cui T, Fang C, Zhou Y, Zhang H, Tian X. NUDT15 polymorphism in healthy children with Bai nationality in Yunnan of China. Pediatr Int 2021;63:790-6. [PMID: 32969567 DOI: 10.1111/ped.14480] [Reference Citation Analysis]
4 Khaeso K, Udayachalerm S, Komvilaisak P, Chainansamit S, Suwannaying K, Laoaroon N, Kuwatjanakul P, Nakkam N, Sukasem C, Puangpetch A, Tassaneeyakul W, Chaiyakunapruk N. Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations. Front Pharmacol 2021;12:784712. [DOI: 10.3389/fphar.2021.784712] [Reference Citation Analysis]
5 Khaeso K, Komvilaisak P, Chainansamit SO, Nakkam N, Suwannaying K, Kuwatjanakul P, Hikino K, Dornsena A, Kanjanawart S, Laoaroon N, Vannaprasaht S, Taketani T, Tassaneeyakul W. NUDT15 is a key genetic factor for prediction of hematotoxicity in pediatric patients who received a standard low dosage regimen of 6-mercaptopurine. Drug Metab Pharmacokinet 2021;43:100436. [PMID: 35016134 DOI: 10.1016/j.dmpk.2021.100436] [Reference Citation Analysis]
6 Sukasem C, Jantararoungtong T, Koomdee N. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings. Drug Metab Pharmacokinet 2021;39:100399. [PMID: 34098253 DOI: 10.1016/j.dmpk.2021.100399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jantararoungtong T, Wiwattanakul S, Tiyasirichokchai R, Prommas S, Sukprasong R, Koomdee N, Jinda P, Rachanakul J, Nuntharadthanaphong N, Pakakasama S, Anurathapan U, Hongeng S, Sukasem C. TPMT*3C as a Predictor of 6-Mercaptopurine-Induced Myelotoxicity in Thai Children with Acute Lymphoblastic Leukemia. J Pers Med 2021;11:783. [PMID: 34442427 DOI: 10.3390/jpm11080783] [Reference Citation Analysis]